Medication

New research from Rutgers University in New Jersey says there could be a new connection between popular diet…

(Gray News) — A popular antidepressant is being recalled for high levels of a potentially cancer-causing chemical. The…

Consider what we ask of a clinical trial. We gather people who differ in nearly every way that…

IDAHO FALLS, Idaho (KIFI) — Many families are reflecting on Fourth of July memories after Melaleuca announced that…

On June 12, SpaceX (NASDAQ: SPCX) had the biggest IPO on record, making $75 billion (1) — but…

The majority of pharmacies (89%) were unable to dispense a medicine at least once a day in the…

GSK plc (LSE/NYSE: GSK) and Spero Therapeutics (Nasdaq: SPRO) today announced that the US Food and Drug Administration…

16 drug combinations banned by Centre over safety concerns NEW DELHI: The Centre has banned 16 fixed-dose combination…

The National Medicines Regulatory Authority (NMRA) plans to revise the maximum retail prices (MRP) of 60 essential medicines…

Regulators issue warning on ads for unlicensed weight loss drugs Chemist+DruggistFirst GLP-1 tablet for weight loss approved in the…

Three months after the patent on semaglutide (the active ingredient in Novo Nordisk’s diabetes and weight-loss drugs like…

For some patients, health leaders warn that missing even a single dose can have “life-threatening consequences” Health leaders…

Rutgers University study connects GLP-1 medications, lower risk of violent behavior